TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Cand Pharm C. Cristoffersen AS
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
22,679
|
21,587
|
19,838 |
| Financial expenses |
6
|
17
|
47 |
| Earnings before taxes |
2,259
|
2,969
|
2,138 |
| Total assets |
12,064
|
11,497
|
9,379 |
| Current assets |
10,893
|
10,161
|
7,765 |
| Current liabilities |
3,720
|
3,953
|
3,186 |
| Equity capital |
8,344
|
7,544
|
6,193 |
| - share capital |
237
|
251
|
238 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
69.2%
|
65.6%
|
66.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.0%
|
13.8%
|
10.8% |
| Return on assets (ROA) |
18.8%
|
26.0%
|
23.3% |
| Current ratio |
292.8%
|
257.0%
|
243.7% |
| Return on equity (ROE) |
27.1%
|
39.4%
|
34.5% |
| Change turnover |
2,226
|
671
|
2,615 |
| Change turnover % |
11%
|
3%
|
15% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.